There are some examples of things we've already done. The regulatory co-operation council, for one, has been very good. That's a great example.
It doesn't mean that Canada has to follow the U.S. lead. With the chemicals work that's been done under RCC, as that work sped up, the U.S. passed its only piece of major bipartisan legislation last year, which was the reform of the Toxic Substances Control Act. Voila, it looks very close to what Canada put in place more than 20 years ago.
We led the way. Through that regulatory co-operation, they followed suit. Now we're drilling down into details where we can discover and share deficiencies, share our science, and reach conclusions on toxicity substances, etc. There's a lot of good news about the co-operation. We can extend that. It doesn't mean that we have to water down what we do and follow the lead of the Americans. We have the capacity to lead.
On your second point, though, about competitiveness, it's something we worry about very much. I mentioned that the U.S. chemistry industry alone has seen over $250 billion of new investment. Canada historically has a 10% share of that. We should have seen 30 new projects valued at $25 billion. We've seen about three or four projects valued at $2 billion. We've seen 1%, so already we're not competitive when it comes to attracting investment.